>
pdufa.bio

ABP 938

Updated ยทnext FDA decision on the calendar

ABP 938 is a Amgen Inc program. Its next catalyst is a Readout in Jul 2027. Every date links its source.

AMGN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Amgen Inc (AMGN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2027AMGN

Questions

When is ABP 938's next FDA decision or readout?

The next tracked catalyst for ABP 938 is a Readout in Jul 2027.

What happened at ABP 938's most recent FDA decision?

No FDA decision for ABP 938 is in our archive yet.

Who makes ABP 938?

Amgen Inc (AMGN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.